HAE
Haemonetics Corp
Price:  
74.61 
USD
Volume:  
472,462.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE Intrinsic Value

43.20 %
Upside

What is the intrinsic value of HAE?

As of 2025-07-01, the Intrinsic Value of Haemonetics Corp (HAE) is 106.81 USD. This HAE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 74.61 USD, the upside of Haemonetics Corp is 43.20%.

The range of the Intrinsic Value is 71.21 - 198.96 USD

Is HAE undervalued or overvalued?

Based on its market price of 74.61 USD and our intrinsic valuation, Haemonetics Corp (HAE) is undervalued by 43.20%.

74.61 USD
Stock Price
106.81 USD
Intrinsic Value
Intrinsic Value Details

HAE Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 71.21 - 198.96 106.81 43.2%
DCF (Growth 10y) 106.05 - 272.29 152.64 104.6%
DCF (EBITDA 5y) 96.39 - 108.63 102.34 37.2%
DCF (EBITDA 10y) 129.11 - 154.51 141.22 89.3%
Fair Value 87.26 - 87.26 87.26 16.95%
P/E 74.44 - 122.86 97.72 31.0%
EV/EBITDA 53.00 - 77.68 69.18 -7.3%
EPV 37.83 - 52.87 45.35 -39.2%
DDM - Stable 32.59 - 93.26 62.93 -15.7%
DDM - Multi 60.37 - 136.07 83.85 12.4%

HAE Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,584.26
Beta 0.79
Outstanding shares (mil) 48.04
Enterprise Value (mil) 4,502.29
Market risk premium 4.60%
Cost of Equity 8.43%
Cost of Debt 4.25%
WACC 7.13%